These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38311411)

  • 1. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
    Yu X; Wang Q; Dai Z
    J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
    Zhang C; Jin Y
    Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway.
    Li J; Yang B
    In Vitro Cell Dev Biol Anim; 2023 Jan; 59(1):19-30. PubMed ID: 36790693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
    Liu Y; Fan D
    Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.
    Liu MY; Liu F; Li YJ; Yin JN; Gao YL; Wang XY; Yang C; Liu JG; Li HJ
    Oxid Med Cell Longev; 2021; 2021():5040326. PubMed ID: 34257801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide‑3 kinase/protein kinase B signaling pathway.
    Zhang D; Wang A; Feng J; Zhang Q; Liu L; Ren H
    Mol Med Rep; 2019 May; 19(5):4019-4026. PubMed ID: 30942438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
    Liu Y; Fan D
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
    Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
    Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
    Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
    Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment.
    Tang M; Deng H; Zheng K; He J; Yang J; Li Y
    Toxicol Appl Pharmacol; 2023 Feb; 460():116378. PubMed ID: 36641037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K/AKT pathway-mediated inflammation and apoptosis.
    Zhou YD; Hou JG; Liu W; Ren S; Wang YP; Zhang R; Chen C; Wang Z; Li W
    Int Immunopharmacol; 2018 Jun; 59():21-30. PubMed ID: 29621733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.
    Cui Y; Su Y; Deng L; Wang W
    Chemotherapy; 2018; 63(5):293-300. PubMed ID: 30731458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways.
    Wang JH; Nao JF; Zhang M; He P
    Tumour Biol; 2014 Dec; 35(12):11985-94. PubMed ID: 25168366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
    Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
    J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
    Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
    J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
    Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ginsenoside Rg5 on cell cycle and invasion of gastric cancer].
    Zhao XY; He ZY; Zai SF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):51-54. PubMed ID: 32476373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.